Mast Therapeutics (MSTX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts MSTX Hot Sheet
Join SI Premium – FREE
Mast Therapeutics (NYSE: MSTX) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $45 thousand versus the consensus estimate of $0 .
For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shotspotter (SSTI) Misses Q2 EPS by 19c; Offers Guidance
- HeartFlow, Inc. (HTFL) Tops Q2 EPS by 12c
- Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
